Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines    

Global DNA vaccines Market Research Report

DNA vaccines and Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, Sub-unit vaccines and Other Vaccine technology adds up to total Animal Vaccines market.

DNA vaccines can be segmented by Types, Geographies, MacroIndicators and Companies. Types of this market are Preventive and Therapeutic. Geographies of this market are North America, Europe, Asia, Rest of World and Other Geographies. MacroIndicators of this market are Healthcare Expenditure. Companies of this market are Pfizer Inc, Sanofi, Merck & Co., Inc., Virbac, Bayer Pharmaceuticals and Other Companies.

 

Key Questions Answered

  • What are market estimates and forecasts; which of DNA vaccines markets are doing well and which are not?
  • What is the competitive landscape; How companies like Pfizer Inc, Sanofi and Merck & Co., Inc. doing in DNA vaccines?
  •  

    What makes our report unique?

    • This report provides market sizing and forecast for the DNA vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    • The reports provides benchmarking insight on the top players Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    • The report provide competitive intelligence on Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    •  

      Audience for this report

      • Global DNA vaccines companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers
show more
PRODUCT TITLE PUBLISHED
North American DNA vaccines Market North American DNA vaccines Market
The North American DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $45.6 million in 2013 and is expected to reach $63.9 million by 2018, at a CAGR of 7.0% during the forecast period. The report on this market analyzes it under six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
European DNA vaccines Market European DNA vaccines Market
The European DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $54.2 million in 2013 and is expected to reach $80.2 million by 2018, at a CAGR of 8.2% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Asian DNA vaccines Market Asian DNA vaccines Market
The Asian DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $24.2 million in 2013 and is expected to reach $47.6 million by 2018, at a CAGR of 14.5%. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539